Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing response to lithium treatment through personalized evaluation
2018-002263-26Phase 4Active
- Sponsor
- Direction de la Recherche Clinique et de l'Innovation
- Start
- Dec 2018
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of lithium in bipolar I disorder and bipolar disorder (BD), sponsored by Direction de la Recherche Clinique et de l'Innovation. Started Dec 2018; status: active.
02
Drugs
lithium
03
Conditions
bipolar I disorderbipolar disorder (BD)
Beyond the preview
Go deeper on 2018-002263-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002263-26.